The global bio-implants market was valued at around US$ 117.3 Billion at the end of 2021. The market is projected to register a 10.0% CAGR and top a valuation of US$ 126.7 Billion by 2032.
Increasing dental implants, rapidly improving healthcare infrastructure, and increasing prevalence of chronic health disordersare expected to uplift the bio-implants market growth.
Bio-Implants are prosthetic devices used to replace, enhance or support a biological structure. They are composed of several biosynthetic components such as tissue-engineered products and collagen such as synthetic skin. The development of technology in the healthcare sector has led to a large increase in the market for bio-implants throughout the years. Although the healthcare sector has had significant technical advancements over the years, the advent of serious medical conditions has complicated the bio-implants market.
Attributes
Details
Bio-Implants Market Value in 2021
US$ 117.3 Billion
Bio-Implants Market Value in 2032
US$ 126.5 Billion
Bio-Implants Market CAGR (2022 to 2032)
10.0%
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
What are the Major Drivers Boosting the Demand for Bio-Implants Market?
The global market for bio-implants is anticipated to grow as a result of the rising prevalence of chronic health diseases particularly in the geriatric population and increasing disposable incomes. The healthcare infrastructure in developed and developing countries is expected to continue to rapidly improve, propelling the market for bio-implants to significant growth rates. Additionally, increasing awareness about the effectiveness of cosmetic implants and technological advancements. The market for bio-implants is rising due to an increase in dental problems worldwide. Due to the rising prevalence of cardiovascular and orthopedic problems, orthopedic artificial implants and cardiac pacemakers are in demand.
Which Region Shows Strong Growth Potential in the Bio-Implants Market?
The established economy of North America is anticipated to drive demand for bio-implants, followed by Europe and other regions. The overall sales of bio-implant control in North America are anticipated to increase as the robust healthcare infrastructure, increased awareness of cosmetic implants, and major key players in the bio-implants market in this region. Furthermore, with technological advancements in healthcare, increased demand for nonsurgical bio-implants, and a rising geriatric population, Europe is the world's second-largest market for bio-implants.
Moreover, as a result of the large production of bio-implants in numerous therapeutic fields and the rising prevalence of chronic diseases, the Middle East and Africa(MEA) region has the potential to be a market for bio-implants.
Find your sweet spots for generating winning opportunities in this market.
Who are the Key Players in the Bio-Implants Market?
Some of the market players operating in the bio-implants market are LifeNet Health, Smith & Nephew, Arthrex, Inc., Clinic Lemanic, Alpha Bio Tec, MiMedx Group, Medtronic, St Jude Medical (Abbott), Stryker Cooperation, DePuy Synthes, Biomet (Zimmer), Exactech, Inc., Cochlear Ltd, Straumann AG. and others.
Scope of Report
Report Attributes
Details
Growth Rate
CAGR of 10.0% from 2022 to 2032
Base Year for Estimation
2021
Historical Data
2012 to 2021
Forecast Period
2022 to 2032
Qualitative Units
Revenue in USD Billion, Volume in Units, and CAGR from 2022 to 2032
Report Coverage
Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis
Segment Covered
Product
Material
Origin
End User
Region
Region Covered
North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East & Africa
Key Countries Profiled
USA
Canada
Brazil
Mexico
Germany
United Kingdom
France
Spain
Italy
China
Japan
South Korea
Malaysia
Singapore
Australia
New Zealand
GCC Countries
South Africa
Israel
Key Players
LifeNet Health
Smith & Nephew
Arthrex, Inc.
Clinic Lemanic
Alpha Bio Tec
MiMedx Group
Medtronic,
St Jude Medical (Abbott)
Stryker Cooperation
DePuy Synthes
Biomet (Zimmer)
Exactech, Inc.
Cochlear Ltd
Straumann AG
Customization
Available Upon Request
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
Key Segments Covered in the Bio-Implants Industry Survey
By Product:
Cardiovascular Implants
Dental Implants
Spinal Bio-implants
Orthopedic Implants
Ophthalmic Implants
Others
By Material:
Ceramics
Polymers
Alloys
Biomaterials Metals
By Origin:
Autograft
Allograft
Xenograft
Synthetic
By End User:
Hospitals
Clinics
Ambulatory Surgical Centers
Others
By Region:
North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East and Africa
Frequently Asked Questions
The global bio-implants market is anticipated to register a CAGR of 10.0% during the forecast period.
The top players in the global bio-implants control market are LifeNet Health, Smith & Nephew, Arthrex, Inc., Clinic Lemanic, Alpha Bio Tec, MiMedx Group, Medtronic, St Jude Medical (Abbott), Stryker Cooperation, DePuy Synthes, Biomet (Zimmer), Exactech, Inc., Cochlear Ltd, Straumann AG.
- Request for Table of Contents -
Complete the form below and we'll get back to you shortly
